Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.98 EUR
−20.94 M EUR
0.00 EUR
32.23 M
About TuHURA Biosciences, Inc.
Sector
Industry
CEO
James A. Bianco
Website
Headquarters
Tampa
Founded
2023
ISIN
US8989201038
FIGI
BBG00ZGWWPB1
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of PL3 is 2.06 EUR — it hasn't changed in the past 24 hours. Watch TuHURA Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TuHURA Biosciences, Inc. stocks are traded under the ticker PL3.
PL3 stock has risen by 1.89% compared to the previous week, the month change is a −13.60% fall, over the last year TuHURA Biosciences, Inc. has showed a −43.07% decrease.
We've gathered analysts' opinions on TuHURA Biosciences, Inc. future price: according to them, PL3 price has a max estimate of 12.91 EUR and a min estimate of 7.74 EUR. Watch PL3 chart and read a more detailed TuHURA Biosciences, Inc. stock forecast: see what analysts think of TuHURA Biosciences, Inc. and suggest that you do with its stocks.
PL3 stock is 4.85% volatile and has beta coefficient of 1.09. Track TuHURA Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is TuHURA Biosciences, Inc. there?
Today TuHURA Biosciences, Inc. has the market capitalization of 105.22 M, it has decreased by −6.83% over the last week.
Yes, you can track TuHURA Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
TuHURA Biosciences, Inc. is going to release the next earnings report on Nov 12, 2025. Keep track of upcoming events with our Earnings Calendar.
PL3 earnings for the last quarter are −0.18 EUR per share, whereas the estimation was −0.12 EUR resulting in a −50.00% surprise. The estimated earnings for the next quarter are −0.13 EUR per share. See more details about TuHURA Biosciences, Inc. earnings.
PL3 net income for the last quarter is −8.08 M EUR, while the quarter before that showed −6.16 M EUR of net income which accounts for −31.24% change. Track more TuHURA Biosciences, Inc. financial stats to get the full picture.
No, PL3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 29, 2025, the company has 19 employees. See our rating of the largest employees — is TuHURA Biosciences, Inc. on this list?
Like other stocks, PL3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TuHURA Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.